Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 11244 | 930 | 33.4 | 44% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 202 | 20434 | CLOPIDOGREL//PRASUGREL//ASPIRIN RESISTANCE |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | 9 ALLYLPURINES | Author keyword | 1 | 50% | 0% | 1 |
| 2 | ANTIPLATELET COMPOUNDS | Author keyword | 1 | 50% | 0% | 1 |
| 3 | HAMILTON GEN HOSP CLIN UNIT | Address | 1 | 50% | 0% | 1 |
| 4 | HOMO N NUCLEOSIDES | Author keyword | 1 | 50% | 0% | 1 |
| 5 | NSP 513 | Author keyword | 1 | 50% | 0% | 1 |
| 6 | STUDIO FISIOPATOL SHOCK CNR | Address | 1 | 50% | 0% | 1 |
| 7 | THIENO PYRIDINES | Author keyword | 1 | 50% | 0% | 1 |
| 8 | CNR STUDIO FISIOPATOL SHOCK | Address | 1 | 25% | 0% | 2 |
| 9 | ENTERIC COATED ASPIRIN | Author keyword | 1 | 25% | 0% | 2 |
| 10 | ALLERGIC INTERSTITIAL NEPHRITIS | Author keyword | 0 | 33% | 0% | 1 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | 9 ALLYLPURINES | 1 | 50% | 0% | 1 | Search 9+ALLYLPURINES | Search 9+ALLYLPURINES |
| 2 | ANTIPLATELET COMPOUNDS | 1 | 50% | 0% | 1 | Search ANTIPLATELET+COMPOUNDS | Search ANTIPLATELET+COMPOUNDS |
| 3 | HOMO N NUCLEOSIDES | 1 | 50% | 0% | 1 | Search HOMO+N+NUCLEOSIDES | Search HOMO+N+NUCLEOSIDES |
| 4 | NSP 513 | 1 | 50% | 0% | 1 | Search NSP+513 | Search NSP+513 |
| 5 | THIENO PYRIDINES | 1 | 50% | 0% | 1 | Search THIENO+PYRIDINES | Search THIENO+PYRIDINES |
| 6 | ENTERIC COATED ASPIRIN | 1 | 25% | 0% | 2 | Search ENTERIC+COATED+ASPIRIN | Search ENTERIC+COATED+ASPIRIN |
| 7 | ALLERGIC INTERSTITIAL NEPHRITIS | 0 | 33% | 0% | 1 | Search ALLERGIC+INTERSTITIAL+NEPHRITIS | Search ALLERGIC+INTERSTITIAL+NEPHRITIS |
| 8 | EARLY GRAFT OCCLUSION | 0 | 33% | 0% | 1 | Search EARLY+GRAFT+OCCLUSION | Search EARLY+GRAFT+OCCLUSION |
| 9 | HMCM 41 | 0 | 33% | 0% | 1 | Search HMCM+41 | Search HMCM+41 |
| 10 | INTRACORONARY THROMBOLYSIS ICT | 0 | 33% | 0% | 1 | Search INTRACORONARY+THROMBOLYSIS+ICT | Search INTRACORONARY+THROMBOLYSIS+ICT |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | PRESYSTEMIC ACETYLATION | 15 | 77% | 1% | 10 |
| 2 | VEIN GRAFT PATENCY | 8 | 26% | 3% | 26 |
| 3 | PLUS DIPYRIDAMOLE | 7 | 46% | 1% | 12 |
| 4 | ANTI COAGULANT THERAPY | 5 | 35% | 1% | 12 |
| 5 | ENTERIC COATED ASPIRIN | 3 | 18% | 2% | 15 |
| 6 | PLATELET CYCLOOXYGENASE | 2 | 21% | 1% | 9 |
| 7 | PATENCY 3 YEARS | 1 | 38% | 0% | 3 |
| 8 | ANTI PLATELET THERAPY | 1 | 50% | 0% | 2 |
| 9 | RELEASE ASPIRIN | 1 | 100% | 0% | 2 |
| 10 | PLATELET CYCLOOXYGENASE INHIBITION | 1 | 21% | 1% | 5 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| CURRENT CONCEPTS - THE USE OF ASPIRIN IN ISCHEMIC-HEART-DISEASE | 1992 | 138 | 60 | 38% |
| ASPIRIN AS A THERAPEUTIC AGENT IN CARDIOVASCULAR-DISEASE | 1993 | 180 | 96 | 27% |
| ANTIPLATELET OR ANTICOAGULANT-THERAPY AFTER CORONARY-ARTERY BYPASS-SURGERY - A META-ANALYSIS OF CLINICAL-TRIALS | 1989 | 55 | 12 | 100% |
| ASPIRIN AND HUMAN-PLATELETS - FROM CLINICAL-TRIALS TO ACETYLATION OF CYCLOOXYGENASE AND BACK | 1989 | 98 | 17 | 53% |
| ASPIRIN FOR MYOCARDIAL-INFARCTION - CLINICAL PHARMACOKINETIC CONSIDERATIONS | 1995 | 11 | 29 | 69% |
| Aspirin: benefit and risk in thromboprophylaxis | 1998 | 20 | 92 | 27% |
| ASPIRIN IN CARDIOVASCULAR-DISEASE | 1988 | 62 | 91 | 40% |
| Cardiac medical therapy in patients after undergoing coronary artery bypass graft surgery - A review of randomized controlled trials | 2005 | 26 | 37 | 22% |
| Prehospital administration of aspirin in patients with unstable angina and acute myocardial infarction | 1996 | 6 | 27 | 30% |
| The primary and secondary prevention of coronary artery disease | 2008 | 134 | 164 | 17% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | HAMILTON GEN HOSP CLIN UNIT | 1 | 50% | 0.1% | 1 |
| 2 | STUDIO FISIOPATOL SHOCK CNR | 1 | 50% | 0.1% | 1 |
| 3 | CNR STUDIO FISIOPATOL SHOCK | 1 | 25% | 0.2% | 2 |
| 4 | BLOOD TRANSFUS MED CLIN HAEMATOL | 0 | 33% | 0.1% | 1 |
| 5 | NEPHROLVET AFFAIRS MED | 0 | 33% | 0.1% | 1 |
| 6 | HLTH SERV DIRECTORATE | 0 | 25% | 0.1% | 1 |
| 7 | VETERINATY MED | 0 | 25% | 0.1% | 1 |
| 8 | CANC UK NHS STAT MED | 0 | 17% | 0.1% | 1 |
| 9 | CARDIAC WELLNESS | 0 | 17% | 0.1% | 1 |
| 10 | THROMBOSIS VASC MED | 0 | 17% | 0.1% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000202299 | VASCULAR SURGERY PROCEDURES//ARTERIOSCLEROSIS SURGERY//BOA TRIAL OFF |
| 2 | 0.0000153618 | TRIFLUSAL//HTB//CAS 322 79 2 |
| 3 | 0.0000150881 | INDOBUFEN//INDOBUFEN ENANTIOMERS//ATHEROSCLEROSIS PERIPHERAL |
| 4 | 0.0000144312 | ASPIRIN RESISTANCE//PFA 100//THROMBOSTAT |
| 5 | 0.0000141326 | TICLOPIDINE//TICLOPIDINE HYDROCHLORIDE//PCA 4230 |
| 6 | 0.0000135236 | SALICYLURIC ACID//SALICYLATE POISONING//SALICYLATE DETERMINATION |
| 7 | 0.0000132374 | ACT STUDY//ASPIRIN DOSE//ANTIOXIDANT DEFENSE MECHANISM |
| 8 | 0.0000128312 | SPONTANEOUS PLATELET AGGREGATION//PARTICLE COUNTING METHOD//AGGREGOMETER |
| 9 | 0.0000107352 | DIPYRIDAMOLE//VASODILATOR DRUG//TUMOR CELL GROWTH AND VIABILITY |
| 10 | 0.0000105980 | COAGULATION ABNORMALITY//D L LYSINACETYLSALICYLATE//SECT CLIN GERONTOL VASC MED |